Hydrothermal synthesis of magnetite/hydroxyapatite composite material for hyperthermia therapy for bone cancer

Setsuaki Murakami, Toshiaki Hosono, Balachandran Jeyadevan, Masanobu Kamitakahara, Koji Ioku

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The magnetite/hydroxyapatite (HA) composite that facilitates direct bonding to bones through HA and generation of heat from magnetite exposed to AC magnetic field is considered suitable for hyperthermia therapies of cancer in bones. Porous magnetite/hydroxyapatite (HA) composite was prepared by a hydrothermal treatment of α-tricalcium phosphate (α-TCP) and nanosized magnetite powder mixture having magnetite concentrations varying between 10 and 50 mass% at 120°C under saturated vapor pressure for 24 h. This composite had micro-sized pores of about 400 μm and submicron-sized pores of about 0.2 μm in size and magnetite particle aggregates were strongly trapped in the cages of rod-shaped HA particles only when the magnetite contents were 30 mass% or less. At magnetite concentrations higher than 30 mass%, the composite cannot hold the particles completely and considered unsuitable for biomedical applications. When magnetite/hydroxyapatite (HA) composites with various magnetite concentrations were exposed to high frequency magnetic field for 10 min, the temperature rise in the composite was a function of magnetite concentration and the temperature rise in 30 mass% was 55°C, which is well above the temperature required for treatment. However generation of higher temperatures, which could be achieved by controlling the magnetic field strength, frequency, and exposure time, may be required because the heat loss due to blood flow, etc., is considered during hyperthermia therapies of cancer in bones.

Original languageEnglish
Pages (from-to)950-954
Number of pages5
JournalNippon Seramikkusu Kyokai Gakujutsu Ronbunshi/Journal of the Ceramic Society of Japan
Volume116
Issue number1357
Publication statusPublished - 2008 Sep
Externally publishedYes

Fingerprint

Hyperthermia therapy
Ferrosoferric Oxide
hyperthermia
Hydrothermal synthesis
Magnetite
Durapatite
Hydroxyapatite
magnetite
bones
therapy
Bone
cancer
composite materials
Composite materials
synthesis
Magnetic fields
magnetic fields
porosity
heat
Temperature

Keywords

  • Composite
  • Hydrothermal
  • Hydroxyapatite
  • Magnetic hyperthermia therapy
  • Magnetite

ASJC Scopus subject areas

  • Ceramics and Composites

Cite this

Hydrothermal synthesis of magnetite/hydroxyapatite composite material for hyperthermia therapy for bone cancer. / Murakami, Setsuaki; Hosono, Toshiaki; Jeyadevan, Balachandran; Kamitakahara, Masanobu; Ioku, Koji.

In: Nippon Seramikkusu Kyokai Gakujutsu Ronbunshi/Journal of the Ceramic Society of Japan, Vol. 116, No. 1357, 09.2008, p. 950-954.

Research output: Contribution to journalArticle

Murakami, Setsuaki ; Hosono, Toshiaki ; Jeyadevan, Balachandran ; Kamitakahara, Masanobu ; Ioku, Koji. / Hydrothermal synthesis of magnetite/hydroxyapatite composite material for hyperthermia therapy for bone cancer. In: Nippon Seramikkusu Kyokai Gakujutsu Ronbunshi/Journal of the Ceramic Society of Japan. 2008 ; Vol. 116, No. 1357. pp. 950-954.
@article{d7a1b5193c89429d8fd9769724fb5e9f,
title = "Hydrothermal synthesis of magnetite/hydroxyapatite composite material for hyperthermia therapy for bone cancer",
abstract = "The magnetite/hydroxyapatite (HA) composite that facilitates direct bonding to bones through HA and generation of heat from magnetite exposed to AC magnetic field is considered suitable for hyperthermia therapies of cancer in bones. Porous magnetite/hydroxyapatite (HA) composite was prepared by a hydrothermal treatment of α-tricalcium phosphate (α-TCP) and nanosized magnetite powder mixture having magnetite concentrations varying between 10 and 50 mass{\%} at 120°C under saturated vapor pressure for 24 h. This composite had micro-sized pores of about 400 μm and submicron-sized pores of about 0.2 μm in size and magnetite particle aggregates were strongly trapped in the cages of rod-shaped HA particles only when the magnetite contents were 30 mass{\%} or less. At magnetite concentrations higher than 30 mass{\%}, the composite cannot hold the particles completely and considered unsuitable for biomedical applications. When magnetite/hydroxyapatite (HA) composites with various magnetite concentrations were exposed to high frequency magnetic field for 10 min, the temperature rise in the composite was a function of magnetite concentration and the temperature rise in 30 mass{\%} was 55°C, which is well above the temperature required for treatment. However generation of higher temperatures, which could be achieved by controlling the magnetic field strength, frequency, and exposure time, may be required because the heat loss due to blood flow, etc., is considered during hyperthermia therapies of cancer in bones.",
keywords = "Composite, Hydrothermal, Hydroxyapatite, Magnetic hyperthermia therapy, Magnetite",
author = "Setsuaki Murakami and Toshiaki Hosono and Balachandran Jeyadevan and Masanobu Kamitakahara and Koji Ioku",
year = "2008",
month = "9",
language = "English",
volume = "116",
pages = "950--954",
journal = "Nippon Seramikkusu Kyokai Gakujutsu Ronbunshi/Journal of the Ceramic Society of Japan",
issn = "0914-5400",
publisher = "Ceramic Society of Japan/Nippon Seramikkusu Kyokai",
number = "1357",

}

TY - JOUR

T1 - Hydrothermal synthesis of magnetite/hydroxyapatite composite material for hyperthermia therapy for bone cancer

AU - Murakami, Setsuaki

AU - Hosono, Toshiaki

AU - Jeyadevan, Balachandran

AU - Kamitakahara, Masanobu

AU - Ioku, Koji

PY - 2008/9

Y1 - 2008/9

N2 - The magnetite/hydroxyapatite (HA) composite that facilitates direct bonding to bones through HA and generation of heat from magnetite exposed to AC magnetic field is considered suitable for hyperthermia therapies of cancer in bones. Porous magnetite/hydroxyapatite (HA) composite was prepared by a hydrothermal treatment of α-tricalcium phosphate (α-TCP) and nanosized magnetite powder mixture having magnetite concentrations varying between 10 and 50 mass% at 120°C under saturated vapor pressure for 24 h. This composite had micro-sized pores of about 400 μm and submicron-sized pores of about 0.2 μm in size and magnetite particle aggregates were strongly trapped in the cages of rod-shaped HA particles only when the magnetite contents were 30 mass% or less. At magnetite concentrations higher than 30 mass%, the composite cannot hold the particles completely and considered unsuitable for biomedical applications. When magnetite/hydroxyapatite (HA) composites with various magnetite concentrations were exposed to high frequency magnetic field for 10 min, the temperature rise in the composite was a function of magnetite concentration and the temperature rise in 30 mass% was 55°C, which is well above the temperature required for treatment. However generation of higher temperatures, which could be achieved by controlling the magnetic field strength, frequency, and exposure time, may be required because the heat loss due to blood flow, etc., is considered during hyperthermia therapies of cancer in bones.

AB - The magnetite/hydroxyapatite (HA) composite that facilitates direct bonding to bones through HA and generation of heat from magnetite exposed to AC magnetic field is considered suitable for hyperthermia therapies of cancer in bones. Porous magnetite/hydroxyapatite (HA) composite was prepared by a hydrothermal treatment of α-tricalcium phosphate (α-TCP) and nanosized magnetite powder mixture having magnetite concentrations varying between 10 and 50 mass% at 120°C under saturated vapor pressure for 24 h. This composite had micro-sized pores of about 400 μm and submicron-sized pores of about 0.2 μm in size and magnetite particle aggregates were strongly trapped in the cages of rod-shaped HA particles only when the magnetite contents were 30 mass% or less. At magnetite concentrations higher than 30 mass%, the composite cannot hold the particles completely and considered unsuitable for biomedical applications. When magnetite/hydroxyapatite (HA) composites with various magnetite concentrations were exposed to high frequency magnetic field for 10 min, the temperature rise in the composite was a function of magnetite concentration and the temperature rise in 30 mass% was 55°C, which is well above the temperature required for treatment. However generation of higher temperatures, which could be achieved by controlling the magnetic field strength, frequency, and exposure time, may be required because the heat loss due to blood flow, etc., is considered during hyperthermia therapies of cancer in bones.

KW - Composite

KW - Hydrothermal

KW - Hydroxyapatite

KW - Magnetic hyperthermia therapy

KW - Magnetite

UR - http://www.scopus.com/inward/record.url?scp=51149105067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51149105067&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:51149105067

VL - 116

SP - 950

EP - 954

JO - Nippon Seramikkusu Kyokai Gakujutsu Ronbunshi/Journal of the Ceramic Society of Japan

JF - Nippon Seramikkusu Kyokai Gakujutsu Ronbunshi/Journal of the Ceramic Society of Japan

SN - 0914-5400

IS - 1357

ER -